Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |